Genetic Testing Market Report 2024 (Global Edition)

Global Genetic Testing Market Report 2024 Market Size Split by Type (Carrier Testing, Prenatal and Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, Predictive and Presymptomatic Testing, ...

Genetic Testing Market Report Description

We have various report editions of Genetic Testing Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Genetic Testing Market Insights Video

Competitive Landscape of the Genetic Testing Market

The genetic testing market is highly competitive, dominated by major players like Illumina and Thermo Fisher Scientific, known for their advanced sequencing technologies and broad product portfolios. Companies such as Abbott and LabCorp offer diverse genetic testing services, including prenatal and cancer diagnostics. Emerging players like 23andMe and Natera are expanding their presence with direct-to-consumer and specialty tests. The market is characterized by rapid technological advancements, strategic partnerships, and increasing investments in research and development.

March 2022: Illumina introduced a new cancer test in Europe designed to analyze a broad spectrum of tumor genes from a single tissue sample. This test aims to assist patients with rare cancers by identifying suitable treatment options. (Source: https://www.illumina.com/company/news-center/press-releases/press-release-details.html?newsid=b67bff7b-5f4f-40d5-9986-e977f5289f80) August 2021: Myriad Genetics introduced the MyRisk Hereditary Cancer test with RiskScore, a global polygenic breast cancer risk assessment tool. This test is validated for women of diverse ancestries and aims to enhance access to genetic testing worldwide, including in Latin America. (Source: https://myriad.com/genetic-tests/myrisk-hereditary-cancer-risk-test/) February 2021: The U.S. Food and Drug Administration approved the first test for detecting Fragile X Syndrome (FXS), a prevalent genetic condition associated with inherited developmental delays and intellectual disabilities. (Source: https://www.fda.gov/news-events/press-announcements/fda-authorizes-marketing-first-genetic-test-aid-diagnosis-fragile-x-syndrome)

Top Companies Market Share in Genetic Testing Industry: (In no particular order of Rank)

• Illumina
• Inc.
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• LabCorp (Laboratory Corporation of America Holdings)
• Quest Diagnostics Incorporated
• Myriad Genetics
• Inc.
• Genomic Health
• Inc. (part of Exact Sciences Corporation)
• Natera
• Inc.
• GeneDx
• Inc.
• 23andMe
• Inc.
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Genetic Testing Market

Which Region Dominates the Genetic Testing Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024. It accounted for around 40% of the global revenue due to the region's advanced healthcare infrastructure, increased awareness about genetic disorders, and a high adoption rate of innovative diagnostic technologies. The region's strong presence of key players and substantial investment in research and development have further fueled market growth. Additionally, supportive government initiatives and policies, along with the increasing prevalence of genetic disorders, have led to a higher demand for genetic testing services in North America.

Which Region is Expanding at the Fastest CAGR?

The Asia Pacific region is growing at the fastest CAGR in the Genetic Testing Market due to the rising awareness of genetic disorders, increasing healthcare expenditure, and the growing adoption of advanced diagnostic technologies. Rapid economic growth in countries like China and India, coupled with expanding healthcare infrastructure, has boosted access to genetic testing. Additionally, government initiatives to improve healthcare services and the increasing prevalence of genetic conditions are driving the demand for genetic testing in the region.

The current report Scope analyzes Genetic Testing Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only. To learn more about geographical trends request the free sample pages. Contact US!

North America Genetic Testing

According to Cognitive Market Research, the global Genetic Testing market size was estimated at USD 19642.6 Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD 7857.04 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.5% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Genetic Testing market with a market size of USD 6199.20 million in 2024 and is projected to grow at a CAGR of 10.3% during the forecast period. The advanced healthcare infrastructure, high awareness of genetic disorders, and significant investments in research and development is driving the Genetic Testing market.
• The Canada Genetic Testing market had a market share of USD 942.84 million in 2024 and is projected to grow at a CAGR of 11.3% during the forecast period. Canada's increasing consumer demand for personalized medicine and preventive healthcare is driving the Genetic Testing market.
• The Mexico Genetic Testing market is projected to witness growth at a CAGR of 11.0% during the forecast period, with a market size of USD 714.99 million in 2024.

Europe Genetic Testing

According to Cognitive Market Research, the global Genetic Testing market size was estimated at USD 19642.6 Million, out of which Europe held the market of more than 30% of the global revenue with a market size of USD 5892.78 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.8% from 2024 to 2031.

• The United Kingdom Genetic Testing market had a market share of USD 989.99 million in 2024 and is projected to grow at a CAGR of 11.6% during the forecast period. In the UK, Genetic Testing sales witness an upswing due to increasing awareness of genetic disorders and advancements in biotechnology.
• The France Genetic Testing market is projected to witness growth at a CAGR of 10.0% during the forecast period, with a market size of USD 542.14 million in 2024.
• According to Cognitive Market Research, the German Genetic Testing market size was valued at USD 1166.77 million in 2024 and is projected to grow at a CAGR of 11.0% during the forecast period. In Germany, Genetic Testing surged due to the presence of major market players.
• The Italy Genetic Testing market is projected to witness growth at a CAGR of 10.2% during the forecast period, with a market size of USD 506.78 million in 2024.
• The Russia Genetic Testing market is projected to witness growth at a CAGR of 9.8% during the forecast period, with a market size of USD 913.38 million in 2024.
• The Spain Genetic Testing market is projected to witness growth at a CAGR of 9.9% during the forecast period with a market size of USD 483.21 million in 2024
• The Luxembourg Genetic Testing market is projected to witness growth at a CAGR of 10.9% during the forecast period, with a market size of USD 182.68 million in 2024.
• The Portugal Genetic Testing market is projected to witness growth at a CAGR of 10.6% during the forecast period, with a market size of USD 123.75 million in 2024.
• The Greece Genetic Testing market is projected to witness growth at a CAGR of 11.1% during the forecast period, with a market size of USD 70.71 million in 2024.
• Rest of Europe's Genetic Testing market is projected to witness growth at a CAGR of 9.5% during the forecast period, with a market size of USD 913.38 million in 2024.

Asia Pacific Genetic Testing

According to Cognitive Market Research, the global Genetic Testing market size was estimated at USD 19642.6 Million, out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 4517.80 million in 2024 and will grow at a compound annual growth rate (CAGR) of 14.3% from 2024 to 2031.

• According to Cognitive Market Research, the China Genetic Testing market size was valued at USD 2033.01 million in 2024 and is projected to grow at a CAGR of 13.8% during the forecast period. Genetic Testing surged in China due to rising healthcare investments, increasing awareness of genetic disorders, and a large, diverse population.
• The Japan Genetic Testing market is projected to witness growth at a CAGR of 12.8% during the forecast period, with a market size of USD 623.46 million in 2024.
• The India Genetic Testing market had a market share of USD 542.14 million in 2024 and is projected to grow at a CAGR of 16.1% during the forecast period. Technological advancements is driving the Genetic Testing market.
• The South Korean Genetic Testing market is projected to witness growth at a CAGR of 13.4% during the forecast period, with a market size of USD 451.78 million in 2024.
• The Australian Genetic Testing market is projected to witness growth at a CAGR of 14.0% during the forecast period, with a market size of USD 234.93 million in 2024.
• The South East Asia Genetic Testing market is projected to witness growth at a CAGR of 15.3% during the forecast period, with a market size of USD 311.73 million in 2024.
• The Rest of Asia Pacific Genetic Testing market is projected to witness growth at a CAGR of 14.1% during the forecast period, with a market size of USD 320.76 million in 2024.

South America Genetic Testing

According to Cognitive Market Research, the global Genetic Testing market size was estimated at USD 19642.6 Million, out of which the Latin America market has more than 5% of the global revenue with a market size of USD 982.13 million in 2024 and will grow at a compound annual growth rate (CAGR) of 11.7% from 2024 to 2031. .

• According to Cognitive Market Research, the Brazil Genetic Testing market size was valued at USD 420.35 million in 2024 and is projected to grow at a CAGR of 12.3% during the forecast period. Genetic Testings flourished in Brazil due to increasing healthcare investments, rising awareness of genetic disorders, and improving healthcare infrastructure.
• Argentina's Genetic Testing market had a market share of USD 165.00 million in 2024 and is projected to grow at a CAGR of 12.6% during the forecast period. Argentina's increasing access to genetic testing services augment the demand.
• Colombia Genetic Testing market is projected to witness growth at a CAGR of 11.5% during the forecast period, with a market size of USD 87.41 million in 2024.
• Peru Genetic Testing market is projected to witness growth at a CAGR of 11.9% during the forecast period, with a market size of USD 80.53 million in 2024.
• Chile Genetic Testing market is projected to witness growth at a CAGR of 12.0% during the forecast period, with a market size of USD 70.71 million in 2024.
• The Rest of Latin America's Genetic Testing market is projected to witness growth at a CAGR of 10.8% during the forecast period, with a market size of USD 158.12 million in 2024.

Middle East and Africa Genetic Testing

According to Cognitive Market Research, the global Genetic Testing market size was estimated at USD 19642.6 Million, out of which the Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 392.85 million in 2024 and will grow at a compound annual growth rate (CAGR) of 12.0% from 2024 to 2031..

• The GCC Countries Genetic Testing market is projected to witness growth at a CAGR of 12.8% during the forecast period, with a market size of USD 168.14 million in 2024. Genetic Testing sales flourish due to the presence of major market players.
• The Egypt Genetic Testing market is projected to witness growth at a CAGR of 12.3% during the forecast period, with a market size of USD 41.25 million in 2024.
• The South Africa Genetic Testing market is projected to witness growth at a CAGR of 13.0% during the forecast period, with a market size of USD 62.07 million in 2024. Genetic Testing sales flourish in South Africa due to increasing healthcare investments, rising awareness of genetic disorders, and advancements in medical technology.
• The Turkey Genetic Testing market is projected to witness growth at a CAGR of 11.5% during the forecast period, with a market size of USD 33.79 million in 2024.
• The Nigeria Genetic Testing market is projected to witness growth at a CAGR of 11.1% during the forecast period, with a market size of USD 41.25 million in 2024.
• The Rest of MEA Genetic Testing market is projected to witness growth at a CAGR of 11.0% during the forecast period, with a market size of USD 46.36 million in 2024.

Genetic Testing Market Analysis

How are Segments PerTechnologying in the Global Genetic Testing Market?

Genetic Testing Market Type Segment Analysis

According to Cognitive Market Research, Carrier Testing stands out as the dominant category. Carrier testing has captured the largest market share in the Genetic Testing Market due to its widespread use in identifying individuals who carry one copy of a gene mutation that, when present in two copies, can lead to genetic disorders. This type of testing is crucial for couples planning families, particularly those with a history of genetic disorders. The increasing awareness of genetic conditions and the growing emphasis on preventive healthcare have further driven the demand for carrier testing, solidifying its dominant market position.

Prenatal and newborn testing is growing at the highest CAGR in the Genetic Testing Market due to increasing awareness of the benefits of early detection of genetic conditions. Advances in non-invasive prenatal testing (NIPT) have made it safer and more accessible for expectant parents. Additionally, rising healthcare expenditure and government initiatives promoting early genetic screening have boosted demand. The growing emphasis on reducing the incidence of genetic disorders and improving infant health outcomes further drives this market segment's rapid growth.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Genetic Testing Industry. Request a Free Sample PDF!

Genetic Testing Market Technology Segment Analysis

According to Cognitive Market Research, the dominant category is Cytogenetic testing. Cytogenetic testing technology captured the largest market share in the Genetic Testing Market due to its broad application in diagnosing chromosomal abnormalities, such as Down syndrome and certain cancers. Its ability to detect structural and numerical chromosomal changes, coupled with advancements in techniques like FISH and CGH, has made it a preferred choice in prenatal, oncology, and rare disease diagnostics. Additionally, its cost-effectiveness and established use in clinical settings further contribute to its dominant market position.

Biochemical testing technology is growing at the highest CAGR in the Genetic Testing Market due to its critical role in diagnosing metabolic disorders and newborn screening. It enables early detection of conditions like phenylketonuria (PKU) through enzyme and metabolite analysis, offering prompt intervention. The rise in awareness and demand for early disease detection, coupled with advancements in mass spectrometry and tandem mass spectrometry, has fueled its adoption. Additionally, its non-invasive nature and expanding applications in personalized medicine are driving its rapid growth.

The above Graph is for representation purposes only. This chart does not depict actual Market share. Please purchase the Genetic Testing market report 2024 Edition by contacting our team.

Genetic Testing Application Segment Analysis

Genetic Testing Market Application Segment Analysis

According to Cognitive Market Research, the dominant category is Genetic disease diagnosis. Genetic disease diagnosis captured the largest market share in the Genetic Testing Market due to the increasing prevalence of inherited disorders and the growing demand for early, accurate diagnosis. Advances in genomic technologies, such as next-generation sequencing, have made it easier to identify genetic mutations associated with conditions like cystic fibrosis, Huntington's disease, and hereditary cancers. Additionally, rising awareness among patients and healthcare providers about the benefits of genetic testing for personalized treatment plans has further driven its dominance in the market.

The "Others" application segment is growing at the highest CAGR in the Genetic Testing Market due to the expanding scope of genetic testing in areas beyond traditional diagnostics, such as ancestry testing, pharmacogenomics, and nutrigenomics. As consumers seek personalized health insights, demand for tests related to drug response, dietary planning, and heritage analysis is surging. Additionally, advancements in direct-to-consumer genetic testing platforms and increasing interest in preventative healthcare are driving rapid growth in this diverse and emerging application category.

• Cancer diagnosis
• Genetic disease diagnosis
• Others

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion